RSPI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RSPI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
RespireRx Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2023 was $-0.002. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-48.89 for the trailing ten years ended in Sep. 2023.
During the past 3 years, the average E10 Growth Rate was 8.20% per year. During the past 5 years, the average E10 Growth Rate was 26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.
During the past 13 years, the highest 3-Year average E10 Growth Rate of RespireRx Pharmaceuticals was 44.50% per year. The lowest was -1.90% per year. And the median was 12.45% per year.
As of today (2024-05-26), RespireRx Pharmaceuticals's current stock price is $0.0007. RespireRx Pharmaceuticals's E10 for the quarter that ended in Sep. 2023 was $-48.89. RespireRx Pharmaceuticals's Shiller PE Ratio of today is .
The historical data trend for RespireRx Pharmaceuticals's E10 can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RespireRx Pharmaceuticals Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
E10 | Get a 7-Day Free Trial | -55.67 | -54.17 | -50.53 | -49.74 | -48.89 |
For the Biotechnology subindustry, RespireRx Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, RespireRx Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where RespireRx Pharmaceuticals's Shiller PE Ratio falls into.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.
What is E10? How do we calculate E10?
E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.
If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.
We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
For example, RespireRx Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2023 was:
Adj_EPS | = | Earnings per Share (Diluted) | / | CPI of Sep. 2023 (Change) | * | Current CPI (Sep. 2023) |
= | -0.002 | / | 129.8595 | * | 129.8595 | |
= | -0.002 |
Current CPI (Sep. 2023) = 129.8595.
RespireRx Pharmaceuticals Quarterly Data
per share eps | CPI | Adj_EPS | |
201312 | 0.000 | 98.326 | 0.000 |
201403 | -64.998 | 99.695 | -84.665 |
201406 | -129.997 | 100.560 | -167.874 |
201409 | -10.346 | 100.428 | -13.378 |
201412 | -32.499 | 99.070 | -42.599 |
201503 | -9.955 | 99.621 | -12.977 |
201506 | -10.839 | 100.684 | -13.980 |
201509 | -16.900 | 100.392 | -21.861 |
201512 | -11.100 | 99.792 | -14.444 |
201603 | -17.600 | 100.470 | -22.748 |
201606 | -14.500 | 101.688 | -18.517 |
201609 | -11.800 | 101.861 | -15.043 |
201612 | -6.400 | 101.863 | -8.159 |
201703 | -6.800 | 102.862 | -8.585 |
201706 | -6.900 | 103.349 | -8.670 |
201709 | -2.700 | 104.136 | -3.367 |
201712 | -1.500 | 104.011 | -1.873 |
201803 | -2.400 | 105.290 | -2.960 |
201806 | -2.000 | 106.317 | -2.443 |
201809 | -1.600 | 106.507 | -1.951 |
201812 | -1.800 | 105.998 | -2.205 |
201903 | -1.400 | 107.251 | -1.695 |
201906 | -1.200 | 108.070 | -1.442 |
201909 | -1.200 | 108.329 | -1.438 |
201912 | -1.610 | 108.420 | -1.928 |
202003 | -1.420 | 108.902 | -1.693 |
202006 | -0.010 | 108.767 | -0.012 |
202009 | -0.010 | 109.815 | -0.012 |
202012 | -0.035 | 109.897 | -0.041 |
202103 | -0.010 | 111.754 | -0.012 |
202106 | -0.010 | 114.631 | -0.011 |
202109 | -0.010 | 115.734 | -0.011 |
202112 | -0.010 | 117.630 | -0.011 |
202203 | -0.010 | 121.301 | -0.011 |
202206 | -0.008 | 125.017 | -0.008 |
202209 | -0.014 | 125.227 | -0.015 |
202212 | -0.009 | 125.222 | -0.009 |
202303 | -0.010 | 127.348 | -0.010 |
202306 | -0.004 | 128.729 | -0.004 |
202309 | -0.002 | 129.860 | -0.002 |
Add all the adjusted EPS together and divide 10 will get our e10.
If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.
For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.
The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.
Thank you for viewing the detailed overview of RespireRx Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.
David Dickason | officer: SVP of Pre-Clinical Prod. Dev. | 126 VALLEY ROAD, SUITE C, GLEN ROCK NJ 07452 |
Timothy L. Jones | director, officer: CEO and President | 126 VALLEY ROAD, SUITE C, GLEN ROCK NJ 07452 |
Manuso James S J | director, officer: President & CEO | 5130 ROUTE 212, WILLOW NY 12495 |
Katie Macfarlane | director | 101 POOR FARM ROAD 3RD FLOOR, PRINCETON NJ 08540 |
Purcell Richard David Jr. | officer: SVP - Research & Deleopment | 65 FAIR HAVEN ROAD, FAIR HAVEN NJ 07704 |
James Sapirstein | director | 1517 SAN JACINTO, HOUSTON TX 77002 |
Marc M Radin | officer: Controller | 33 FRANKLIN PLACE, GLEN ROCK NJ 07452 |
Robert N Weingarten | director, officer: Vice President and CFO | 5439 LOCKHURST DRIVE, WOODLAND HILLS CA 91367 |
Aurora Capital Llc | other: Member of a 10% owner group | 354 WIDOW GAVITS ROAD, PO BOX 1167, BRIDGEHAMPTON, NY 11932-1167 |
Aurora Capital Corp | other: Member of 10% owner group | |
Jeff Eliot Margolis | director, officer: Vice President, Sec. & Treas., other: Member of 10% owner group | C/O AURORA CAPITAL LLC, 17 PARK AVENUE, #201, NEW YORK NY 10016 |
Steven Chizzik | other: Member of 10% owner group | C/O THE VERRAZANO GROUP, LLC, 2204 MORRIS AVENUE, SUITE 203A, UNION NJ 07083 |
Arnold Lippa | director, officer: Chairman, CEO and President, other: Member of 10% owner group | C/O AURORA CAPITAL, LLC, 17 PARK AVENUE, #201, NEW YORK NY 10016 |
T. Morgen Capital Llc | other: Member of 10% owner group | C/O AURORA CAPITAL LLC, 17 PARK AVENUE, #201, NEW YORK NY 10016 |
Kenneth M Cohen | other: Member of 10% owner group | 12750 HIGH BLUFF DRIVE, SUITE 310, SAN DIEGO CA 92130 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 07-05-2022
By Stock market mentor Stock market mentor • 01-12-2023
By GuruFocusNews GuruFocusNews • 05-27-2022
By GuruFocusNews GuruFocusNews • 06-03-2022
By GuruFocusNews GuruFocusNews • 06-23-2022
By Value_Insider Value_Insider • 11-17-2022
By GuruFocusNews GuruFocusNews • 06-06-2022
By sperokesalga sperokesalga • 05-24-2023
By Value_Insider Value_Insider • 12-05-2022